ClinicalTrials.Veeva

Menu

Functional and Proprioceptive Status in Patients With Hemophilic Ankle Arthropathy

I

Investigación en Hemofilia y Fisioterapia

Status

Completed

Conditions

Haemophilia

Treatments

Other: Hemophilia group

Study type

Observational

Funder types

Other
NETWORK

Identifiers

NCT05425888
He-AnkleCon

Details and patient eligibility

About

Introduction: Hemophilic ankle arthropathy is manifested by functional degenerative alterations (muscle strength deficit, mobility and proprioception), intra-articular and chronic pain.

Design: Case-control study. Objective: To observe the differences between patients with hemophilic ankle arthropathy and their healthy peers, regarding dorsiflexion, dorsiflexion strength, biomechanical analysis of gait and balance, and functionality.

Patients: 10 patients with hemophilic ankle arthropathy and 12 healthy subjects without ankle joint damage.

Measurement instruments and study variables: dorsiflexion (range of motion), dorsiflexion strength (dynamometry), biomechanical analysis of gait and balance (RS SCAN® model platform), and functionality (2 Minute Walk Test).

Expected results: Analyze the main differences and their relationship based on the clinical and independent variables of patients with hemophilia, compared to their healthy peers.

Enrollment

32 patients

Sex

Male

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients diagnosed with hemophilia A and B.
  • Over 18 years.
  • With medical diagnosis of ankle arthropathy.
  • With clinical evaluation by Hemophilia Joint Health Score.
  • In prophylactic treatment or on demand with FVIII / FIX concentrates for coagulation.
  • No previous hemarthrosis of the ankles in the 3 months prior to evaluation.

Exclusion criteria

  • Patients with inhibitors (antibodies against FVIII or FIX).
  • Patients with neurological or cognitive disorders that prevent the understanding of questionnaires and physical tests.
  • Failure to sign the informed consent document

Trial design

32 participants in 2 patient groups

Hemophilia group
Description:
Group of adult patients with hemophilia, diagnosed with bilateral hemophilic ankle arthropathy
Treatment:
Other: Hemophilia group
Control group
Description:
Group of healthy subjects with sociodemographic characteristics similar to patients with hemophilia, diagnosed with bilateral hemophilic ankle arthropathy.
Treatment:
Other: Hemophilia group

Trial contacts and locations

1

Loading...

Central trial contact

Rubén Cuesta-Barriuso, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems